Back

Empagliflozin treatment rescues abnormally reduced Na+ currents in ventricular cardiomyocytes from dystrophin-deficient mdx mice

31 August 2024 (14:00 - 14:50)
Organised by: Logo
Congress Presentation Part of: Antidiabetic drugs for treatment of cardiovascular disease Ion Channels, Electrophysiology ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speakers

Photo
Doctor Jakob Sauer

Vienna (Austria)

Photo
Ms Jessica Marksteiner

Medical University of Vienna, Vienna (Austria)

7 More presentations in this session

Presentation thumbnail
Human epicardial adipose tissue-derived factors promote atrial endothelial dysfunction: role of pro-inflammatory cytokines and AT1R/NADPH oxidases/SGLT2 pro-oxidant pathway
Doctor W. Fakih (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Takotsubo syndrome induced oxidative stress and endothelial dysfunction in left ventricle of rat model: association with NADPH oxidases/SGLT2 pro- oxidant pathway
Miss T. Tatarcheh (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Investigating the effects of empagliflozin on myocardial metabolic and lipid profile in healthy and metabolic syndrome murine models following acute myocardial infarction
Professor I. Andreadou (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Semaglutide improves contractile function in isolated human atrium
Doctor P. Hegner (Regensburg, DE)
Abstract Slides Video
Presentation thumbnail
Effects of empagliflozin on cardio-renal interaction in heart failure with reduced ejection fraction: results from in-vivo experiments and the CINNAMON-study
Doctor F. Sinha (Regensburg, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Antidiabetic drugs for treatment of cardiovascular disease

The Event

Event poster

ESC Congress 2024

31 August 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Tenascin-C inhibition rescues abnormally reduced Na currents in dystrophin-deficient ventricular cardiomyocytes
thumbnail
Congress Presentation
Reduced Na current in dystrophin-deficient ventricular cardiomyocytes is rescued by tenascin-C inhibition
thumbnail
Congress Presentation
High-throughput proteomic analysis unveils metabolic and mitochondrial signaling rewiring by chronic ivabradine treatment in duchenne muscular dystrophy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources